Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy

Abstract EN

Common variable immunodeficiency is the most common form of symptomatic primary antibody failure in adults and children.

Replacement immunoglobulin is the standard treatment of these patients.

By using a differential proteomic approach based on 2D-DIGE, we examined serum samples from normal donors and from matched, naive, and immunoglobulin-treated patients.

The results highlighted regulated expression of serum proteins in naive patients.

Among the identified proteins, clusterin/ApoJ serum levels were lower in naive patients, compared to normal subjects.

This finding was validated in a wider collection of samples from newly enrolled patients.

The establishment of a cellular system, based on a human hepatocyte cell line HuH7, allowed to ascertain a potential role in the regulation of CLU gene expression by immunoglobulins.